Simultaneous identification and quantification of canrenone and 11-α-hydroxy-canrenone by LC-MS and HPLC-UVD

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Huang, Da Ming ^a   Zhang, Tian Zhen ^a   Cui, Feng Jie ^a   Sun, Wen Jing ^a,b   Zhao, Li Ming ^c   Yang, Meng Yi ^a   Wang, Ya Juan ^a  

^a JIANGSU UNIVERSITY   (China)

^b Parchn Sodium Isovitamin C Co Ltd   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

11ALPHA HYDROXYCANRENONE; CANRENONE; METHANOL; UNCLASSIFIED DRUG; WATER; 11 HYDROXYCANRENONE; 11-HYDROXYCANRENONE; DRUG DERIVATIVE;

ARTICLE; CAPILLARY CHROMATOGRAPHY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG TRANSFORMATION; ELUTION; FLOW RATE; GAS FLOW; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE TRANSITION; SPECTRAL SENSITIVITY; TEMPERATURE; ULTRAVIOLET DETECTOR; ULTRAVIOLET RADIATION; VALIDATION PROCESS; BIOTRANSFORMATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOTRANSFORMATION; CANRENONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MASS SPECTROMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84855560299     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/917232     Document Type: Article

References (22)

1. Werner S., Christine M., Eber B., Barbara E., Intoxication due to negative canrenone interference in digoxin drug monitoring The Lancet 1999 354 9185 1176 1177 (Pubitemid 29460450)
2. Marrs B., Delagrave S., Murphy D., Novel approaches for discovering industrial enzymes Current Opinion in Microbiology 1999 2 3 241 245 (Pubitemid 29260141)
3. Preisig C. L., Laakso J. A., Mocek U. M., Wang P. T., Baez J., Byng G., Biotransformations of the cardiovascular drugs mexrenone and canrenone Journal of Natural Products 2003 66 3 350 356 (Pubitemid 36384010)
4. Megges R., Weiland J., Undeutsch B., Bchting H., Schn R., The nitration of canrenone with acetic anhydride/nitric acid Steroids 1997 62 12 762 766 (Pubitemid 28012061)
5. McMahon E. G., Recent studies with eplerenone, a novel selective aldosterone receptor antagonist Current Opinion in Pharmacology 2001 1 2 190 196 (Pubitemid 33586411)
6. Burgess E. D., Lacourciere Y., Ruilope-Urioste L. M., Oparil S., Kleiman J. H., Krause S., Roniker B., Maurath C., Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension Clinical Therapeutics 2003 25 9 2388 2404 (Pubitemid 37267247)
7. Davis K. L., Nappi J. M., The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist Clinical Therapeutics 2003 25 11 2647 2668 (Pubitemid 37510583)
8. White W. B., Carr A. A., Krause S., Jordan R., Roniker B., Oigman W., Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension The American Journal of Cardiology 2003 92 1 38 42 (Pubitemid 36782306)
9. Gladiali S., Gallotti A., Vitali R., Gardi R., Facilitated reduction of 11-ketone in corticosteroid 17,21-diacetates Chemistry and Industry 1977 24 982 983 (Pubitemid 8253948)
10. Nussium M., Sondheimer F., New synthesis of 11-oxygenated steroids Chemistry Industry 1960 4 400 401
11. Du L. X., Jia S. J., Lu F. P., Morphological changes of Rhizopus chinesis 12 in submerged culture and its relationship with antibiotic production Process Biochemistry 2003 38 12 1643 1646
12. Reyes A. J., Leary W. P., Crippa P., The aldosterone antagonist and facultative diuretic eplerenone: a critical review European Journal of Internal Medicine 2005 16 1 3 11 (Pubitemid 40283294)
13. Gharaee Fathabad E., TabatabaeiYazdi M., Faramarzi M. A., Biotransformation of Hydroeortisone by Neurospora crassa Journal of Sciences, Islamic Republic of Iran 2006 17 4 309 312
14. Romano A., Romano D., Ragg E., Costantino F., Lenna R., Gandolfi R., Molinari F., Steroid hydroxylations with Botryodiplodia malorum and Colletotrichum lini Steroids 2006 71 6 429 434
15. Sora D. I., Udrescu S., Albu F., David V., Medvedovici A., Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples Journal of Pharmaceutical and Biomedical Analysis 2010 52 5 734 740
16. Sandall J. M., Millership J. S., Collier P. S., McElnay J. C., Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples Journal of Chromatography B 2006 839 1-2 36 44 (Pubitemid 44056042)
17. Zhang H., Stewart J. T., Liquid chromatographic determination of canrenone in human serum using solid-phase extraction Journal of Pharmaceutical and Biomedical Analysis 1993 11 11-12 1341 1344 (Pubitemid 24019315)
18. Jankowski A., Skorek-Jankowska A., Lamparczyk H., Simultaneous determination of spironolactone and its metabolites in human plasma Journal of Pharmaceutical and Biomedical Analysis 1996 14 8-10 1359 1365 (Pubitemid 26235199)
19. Kaukonen A. M., Vuorela P., Vuorela H., Mannermaa J. P., High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum Journal of Chromatography A 1998 797 1-2 271 281 (Pubitemid 28156970)
20. Martin E., Jimenez A. I., Hernandez O., Simultaneous kinetic spectrophotome- tric determination of spironolactone and canrenone in urine using partial least-squares regression Talanta 1999 49 1 143 154
21. Herraez-Hernandez R., Soriano-Vega E., Campins-Falco P., High-performance liquid chromatographic determination of spironolactone and its major metabolite canrenone in urine using ultraviolet detection and column-switching Journal of Chromatography B 1994 658 2 303 310 (Pubitemid 24268461)
22. De Croo F., Van den Bossche W., De Moerloose P., Simultaneous quantitative determination of butizide, potassium canrenoate and canrenone in tablets by high-performance liquid chromatography Journal of Chromatography A 1986 354 367 373 (Pubitemid 16072401)